The effects of dosage variation in black seed cumin oil (Nigella sativa L.) use on HbA1c levels and interleukin-17A expression in patients at risks of metabolic syndrome

Vitri Agustiarini, Endang Darmawan, Akrom Akrom

Abstract


Metabolic syndrome causes an imbalance of the immune system and increased levels of HbA1c and IL-17A expression. Black cumin seed oil (BCSO) is known to have antioxidant and immunomodulatory  properties. This study reports the effects of dosage variation in BCSO (1.5 and 3 ml per day for 20 days) on HbA1c levels and IL-17A expression in patients at risk of metabolic syndrome at Jetis 1 Public Health Center in Bantul, Yogyakarta. It employed a crossover design in which a total of 66 patients at risk of metabolic syndrome were divided into two groups receiving a sequence of different treatments. Group 1 (N=33) received treatment A first, which was BCSO at a dose of 1.5 ml/day for 20 days. Then, after a washout period of 7 days, it received treatment B, 3 ml of BCSO per day for 20 days. Group 2 followed the same procedure only vice versa, treatment B, then A. The HbA1c levels were measured by the mean plasma glucose (MPG) method, while the IL-17A expression was detected by flow cytometry. The average HbA1c level and IL-17A expression of the treatment groups were statistically analyzed with 95% confidence level. In response to the treatment regime, the HbA1c level of group 1 was 7.34 ± 2.51% (a decrease), and that of group 2 was 7.72 ± 2.44% (an increase). The IL-17 expression in group 1 was 3.74 ± 3.52% (a decrease), and the one in group 2 was 4.07 ± 3.65% (an increase). The effects of administering 1.5 ml and 3 ml BCSO per day for 20 consecutive days on Hb1c level (p=0.17) and IL-17A expression (p=0.67) were not significantly different. Most patients experience a decrease in HbA1c levels and IL-17A expression after the treatment. Insignificant differences between the two groups mean that at the doses of 1.5 ml/day and 3 ml/day for 20 days, BCSO exhibits the same effects in patients at risk of metabolic syndrome registered at Jetis 1 Public Health Center in Bantul, Yogyakarta.


Keywords


Keywords: Metabolic Syndrome; BCSO; HbA1c; IL-17A

Full Text:

PDF

References


Ahmad, A., Husain A., Mujeeb M., Khan., Najmi A.K., Siddique N.A., Damanhouri Z.A., Anwar F., 2013, A Review On Therapeutic Potential Of Nigella Sativa: A Miracle Herb, Asian Pacific Journal of Tropical Biomedicine, 3(5): 337-352.

American Diabetes Association., 2017, Standards of Medical Care in Diabetes: Promoting Health and Reducing Disparities in Populations, Diabetes Care, 40 (1): S6-S10.

Andaloussi, AB., Martinean, LC., Spor D., Vuong T., Leduc, C., Joly E., 2008, Antidiabetic Activity Of Nigella Sativa Seed Extract In Cultured Pancreatic-Î’ Cells, Skeletal Muscle Cells And Adipocytes. Pharmaceutical Biology Journals, 46(1-2): 96-104.

Andrew, S.P., Van Belle, T., Wurster, A.L., Suto A., Michaud, M., Zhang, D., Grusby, M.J., Herrath, M.V, 2009, Interleukin-21 Is Required For The Development Of Type I Diabetes In NOD Mice, Diabetes, 58(5):1144-1155.

Anggraeni, D., 2007, Mewaspadai Adanya Sindrom Metabolic. (Online).

(Retrieved from http://labcito.co.id. on December 24, 2016).

Ansari, Z.M., Mohammad, N., Rahat, A.K., Shahzad, F.H, 2017, Protective Role Of Nigella Sativa In Diabetic Nephropathy: A Randomized Clinical Trial, Saudi Journal of Kidney Diseases and Transplantation, 28(1):9-14.

Bamosa, A.O., Kaatabi, H., Lebdaa, F.M., Elq A.M., Al-Sultanb A., 2010, Effect Of Nigella Sativa Seeds On The Glycemic Control Of Patients With Type 2 Diabetes Mellitus, Indian journal of physiology and pharmacology, 54(4):344-54.

Cohen, Joseph M., 2014, Top 27 Scientific Health Benefits of the Panacea Black

Cumin Seed (Nigella sativa), Retrieved on September 24, 14:27 WIB

De Carvalho, V.F., Bressan, J., Babio, N., Salas-Salvado, J., 2013, Prevalence Of Metabolic Syndrom In Brazilian Adults: A Systematic Review, BMC Public Health, 13:1198.

Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., Garg, R., 2005, Metabolic Syndrome: A Comprehensive Perspective Based On Interaction Between Obesity And Diabetes, Circulation, 111(11):1448-1454.

Dehkordi, F.R, and A.F. Kamkhah., 2008, Antihypertensive Effect Of Nigella Sativa L. Seed Extract In Patients With Mild Hypertension, Fundam Clin Pharmacol, 22(4):447-452.

Fallah H.H., Amini M., Mohtashami R., Gramarchehre M. E., 2013, Blood Pressure Lowering Effect Of Niglle Sativa L. Seed Oil In Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Phytother Res, 27(12): 1849-1853.

Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., Shimomura, I., 2004, Increased Oxidative Stress In Obesity And Its Impact On Metabolic Syndrome, The Journal of Clinical Investigation, 114(12):1752-1761.

Geistanger, A, Arends S, Berding C., 2008, Statistical Methods For Monitoring The

Relationship Between The IFCC Reference Measurement Procedure For

Hemoglobin A1c And The Designated Comparison Method In The United

States, Japan, Sweden. Clinical Chemistry, 54(8):1379-85.

Heshmati, J., Namazi, N., 2015, Effects of black seed (Nigella sativa) on metabolic parameters in diabetes mellitus: a systematic review, Complementary Therapies Medicine, 23(2):275-282.

Hosseini, M.S., Mirkarimi, S.A., Amini, M., Mohtashami, R., Kianbakht, S., Fallah, Hosseini H., 2013, Effects Of Nigella Sativa L. Seed In Type II Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Journal of Medicinal Plants, 12(47): 93-99.

International Diabetes Federation., 2006,The IDF Consensus Worldwide Defenition of the Metabolic Syndrome, (online) (www.idf.org) 25 September 2017: 14:27, Indonesia.

Islam, Muhammad, T., 2016, Biological activities and therapeutic promises of Nigella sativa L., International journal of pharma sciences and scientific research, Departement of pharmacy Southern University Bangladesh, Bangladesh, 2(6): 242-243.

Jaarin, K., Foong, W.D., Yeoh, M.H., Kamarul, Z.Y.N., Qodriyah, H.M.S, Azman, A., Zuhair, J.S.F, Juliana, A.H., Kamisah, Y., 2015, Mechanisms Of The Antihypertensive Effects Of Nigella Sativa Oil In L-Name- Induce Hypertensive Rats, Clinics: 70 (11):751-757.

Kern, PA, Ranganathan S, Li C, Wood L, Ranganathan G., 2001, Adipose Tissue

Tumor Necrosis Factor And Interleukin-6 Expression In Human Obesity And

Insulin Resistance. American Journal of Physiology-Endocrinology and Metabolism, 280 (5): 745-751.

Keyhanmanesh, R., Saadat, S., Mohammadi, M., Shahbazfar, A.A., Fallahi, M., 2015, The Protective Effect of α-Hederin, the Active Constituent of Nigella sativa, on Lung Inflammation and Blood Cytokines in Ovalbumin Sensitized Guinea Pigs, 29(11):1761-1767.

Kumar, N.P., George, P.J., Kumaran, P., Dolla, C.K., Nutman, T.B., Babu, S., 2014, Diminished Systemic And Antigen-Specific Type 1, Type 17, And Other Proinflammatory Cytokines In Diabetic And Prediabetic Individuals With Latent Mycobacterium Tuberculosis Infection, The Journal of Infectious Diseases, 210(10):1670-1678.

Mohtashami, A., Mohammad, H.E., 2016, Effects Of Nigella Sativa Supplementation On Blood Parameters And Anthropometric Indices In Adults: A Systematic Review On Clinical Trials, Journal of Research in Medical Sciences, 7(04): 213-219.

Nady, S., Hoover, J.I., Shata., Mohamed, T., 2009, Interleukin-12 Is the Optimum Cytokine To Expand Human Th17 Cells In Vitro, Clinical and Vaccine Immunology: 16(6): 798-805.

Najmi, A, Nasiruddin, M., Khan, R.A., Haque, S.F., 2012, Therapeutic Effect Of NS (Nigella Sativa L.) In Patients Of Poor Glycemic Control, Asian Journal of Pharmaceutical and Clinical Research, 5:224-228.

Nathan, D.M., Kuenen, J., Borg, R., 2008, A1C-Derived Average Glucose Study

Group. Translating the A1C Assay into Estimated Average Glucose

Values. Diabetes Care, 31: 1473-1478.

Novak, M., Bjorck, L., Welin, C., Manhem, K.., Rosengren, A., 2013, Gender Differences In The Prevalence Of Metabolic Syndrome In 50-Year-Old Swedish Men And Women With Hypertension Born In 1953, Journal of Human Hypertension, 27(1): 56-61.

Rahmatini., 2010, Evaluasi Khasiat Dan Keamanan Obat (Uji Klinik), Majalah

Kedokteran Andalas, 1(34) : 31-38.

Randhawa, M.A., Al-Ghamdi, M.S., 2002, A Review Of The Pharmaco-Therapeutic Effects Of Nigella Sativa, Pakistan Journal of Medical Research, 41 (2): 77-83.

Smeltzer, suzanne C., Barebrenda G., 2002, Buku Ajar Keperawatan Medikal

Bedah Brunner dan Suddarth (Ed.8, Vol.1,2) EGC: Jakarta.

Soegondo, 2008. Hidup Secara Mandiri dengan Diabetes Melitus, Kencing Manis,

Sakit Gula, FK UI, Jakarta.

Stehouwer, C. D., Henry, R. M., Ferreira, I., 2008, Arterial Stiffness In Diabetes

And The Metabolic Syndrome: A Pathway To Cardiovascular Disease,

Diabetologia, 51(4):527-539.

Zareian, P., Dizgah, I.M., 2014, Serum Interleukin 17 in Type 2 Diabetes Mellitus, Journal of Archives in Military Medicine, 2(4):e24689.




DOI: http://dx.doi.org/10.12928/pharmaciana.v9i2.8055

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Vitri Agustiarini, Endang Darmawan, Akrom Akrom

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


 
Pharmaciana
ISSN Print: 2088-4559 | ISSN Online: 2477-0256
Website: http://journal.uad.ac.id/index.php/PHARMACIANA
Office: Faculty of  Pharmacy, Universitas Ahmad Dahlan
Jl. Prof. Dr. Soepomo, S.H., Janturan, Warungboto, Umbulharjo, Yogyakarta, Indonesia
Kode pos 55164
Email: pharmaciana@pharm.uad.ac.id